# US 2006/0078876 A1 · Methods of determining deficiencies in intracellular levels of cysteine and glutathione

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0078876 A1
- Document ID: US20060078876A1
- Status: Published application
- Kind: A1
- Application number: 11/235,683
- Filed: 2005-09-26
- Published: 2006-04-13
- Earliest claimed: 1996-09-03
- Assignees: Research Development Foundation
- Inventors: J. Crawford
- Web page: https://patentgrep.com/patent/US20060078876A1

## CPC

- G01N 33/5047: {Cells of the immune system}
- C12Q 1/28: involving peroxidase
- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- G01N 33/5091: {for testing the pathological state of an organism}
- G01N 33/6812: {Assays for specific amino acids}
- G01N 33/6815: {containing sulfur, e.g. cysteine, cystine, methionine, homocysteine}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention provides cell culture media and methods useful for determining levels of intracellular function of glutathione or cysteine and for providing biochemical analysis of antioxidant function in human lymphocytes.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

A method for determining an antioxidant deficiency in a lymphocyte the method comprising determining the level of intracellular cysteine in the lymphocyte by measuring lymphocyte growth in a serum-free medium comprising cumene hydroperoxide and N-acetyl-L-cysteine (NAC).

### Claim 18 (depends on 17)

The method of claim 17, performed with a plurality of lymphocytes.

### Claim 19 (depends on 17)

The method of claim 17, wherein the NAC is present in a concentration of about 150 mM.

### Claim 20 (depends on 17)

The method of claim 17, wherein the cumene hydroperoxide is present in a concentration of about 5 μM to about 500 μM.

### Claim 21 (depends on 17)

The method of claim 17, wherein the serum-free medium further comprises chloride ion, phosphate ion, calcium ion, magnesium ion, potassium ion, sodium ion or iron ion.

### Claim 22 (depends on 17)

The method of claim 17, wherein the serum-free medium further comprises a biologically utilizable form of pantothenic acid or choline.

### Claim 23 (depends on 17)

The method of claim 17, wherein the serum-free medium further comprises a mitogen, wherein said mitogen stimulates lymphocyte growth.

### Claim 24 (depends on 17)

The method of claim 17, wherein the serum-free medium further comprises one or more supplemental nutrient wherein the supplemental nutrient is:
i) an L-amino acid;
ii) a vitamin; or
iii) at least one of pyruvate, adenine or inositol.

### Claim 25 (depends on 24)

The method of claim 24, wherein the L-amino acid is L-arginine, L-cysteine, L-glutamine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-serine, L-threonine, L-tryptophan, L-tyrosine, and L-valine.

### Claim 26 (depends on 24)

The method of claim 24, wherein the vitamin is biotin, folinic acid, nicotinamide, nicotinic acid, riboflavin, thiamin, vitamin B6 or vitamin B12.

### Claim 27 (depends on 17)

The method of claim 17, wherein measuring growth of the lymphocyte is by measuring radioactive thymidine incorperation.

### Claim 28 (depends on 17)

The method of claim 17, further comprising separately determining the intracellular glutathione levels in a lymphocyte by measuring lymphocyte growth in a second serum-free medium comprising L-Buthionine-[S,R]-Sulfoximine (BSO).

### Claim 29 (depends on 28)

The method of claim 28 wherein the BSO is present in a concentration of about 5 μM.

### Claim 30 (depends on 28)

The method of claim 28, wherein the second serum-free medium further comprises chloride ion, phosphate ion, calcium ion, magnesium ion, potassium ion, sodium ion or iron ion.

### Claim 31 (depends on 28)

The method of claim 28, wherein second the serum-free medium further comprises a biologically utilizable form of pantothenic acid or choline.

### Claim 32 (depends on 28)

The method of claim 28, wherein the second serum-free medium further comprises a mitogen, wherein said mitogen stimulates lymphocyte growth.

### Claim 33 (depends on 28)

The method of claim 28, wherein the second serum-free medium further comprises one or more supplemental nutrient wherein the supplemental nutrient is:
i) an L-amino acid;
ii) a vitamin; or
iii) at least one of pyruvate, adenine or inositol.

### Claim 34 (depends on 33)

The method of claim 33, wherein the L-amino acid is L-arginine, L-cysteine, L-glutamine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-serine, L-threonine, L-tryptophan, L-tyrosine, and L-valine.

### Claim 35 (depends on 33)

The method of claim 33, wherein the vitamin is biotin, folinic acid, nicotinamide, nicotinic acid, riboflavin, thiamin, vitamin B6 or vitamin B12.

### Claim 36 (depends on 28)

The method of claim 28, wherein measuring growth of the lymphocyte is by measuring radioactive thymidine incorperation.

### Claim 37 (depends on 17)

A method for determining if an individual has an antioxidant deficiency by determining the level of intracellular cysteine in a lymphocyte from the individual by the method of claim 17.

### Claim 38 (depends on 37)

The method of claim 37, further comprising determining if the individual has a glutathione deficiency by determining the intracellular glutathione levels of a lymphocyte from the individual by measuring lymphocyte growth in a second serum-free medium comprising L-Buthionine-[S,R]-Sulfoximine (BSO).
